Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges.
about
Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma
P2860
Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Predictive molecular biomarker ...... rogress and future challenges.
@en
type
label
Predictive molecular biomarker ...... rogress and future challenges.
@en
prefLabel
Predictive molecular biomarker ...... rogress and future challenges.
@en
P2093
P2860
P1476
Predictive molecular biomarker ...... rogress and future challenges.
@en
P2093
Jason Yongsheng Chan
Min-Han Tan
Yukti Choudhury
P2860
P304
P356
10.1586/14737159.2015.1032261
P577
2015-04-03T00:00:00Z